Sangamo Therapeutics
SGMO
SGMO
193 hedge funds and large institutions have $571M invested in Sangamo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.
Holders
193
Holders Change
–
Holders Change %
0%
% of All Funds
2.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
59
Reduced
59
Closed
28
Calls
$7.57M
Puts
$5.1M
Net Calls
+$2.47M
Net Calls Change
+$276K
Top Buyers
1 |
1
Millennium Management
New York
|
$9.78M |
2 |
2
HighTower Advisors
Chicago,
Illinois
|
$7.14M |
3 |
3
D.E. Shaw & Co
New York
|
$4.16M |
4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$3.63M |
5 |
5
BlackRock
New York
|
$87.5M |